Women's Health Archives - Page 2 of 6 - LifeScienceHistory.com

Breast and ovarian cancer linked to thousands of gene variants

On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…

False-positive mammogram results discourage some women from future screenings

On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…

NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data

On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…

Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations

On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…

American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024

On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…

asian history month

Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…

U.S. Preventive Services Task Force recommended all women get screened for breast cancer every other year aged 40 to 74

On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

NIH-supported researchers created single-cell atlas of the placenta during term labor

On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…

Flu vaccination during pregnancy decreased flu hospitalizations and emergency visits in infants younger than 6 months

On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…

The White House lanuched Initiative on Women’s Health Research

On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…

High levels of particulate air pollution associated with increased breast cancer incidence

On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…

FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing

On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…

U.S. FDA approved ZURZUVAE (zuranolone), the First and only oral treatment for Women with postpartum depression

On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…

U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40

On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

FDA updated mammography regulations to require reporting of breast density information and facility oversight

On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…

WHO launched new roadmap on breast cancer

On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…

Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length

On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…

FDA approved first targeted therapy for HER2-low breast cancer

On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…

Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology

On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…

Major study linked breast cancer treatment with increased risk of cardiovascular disease

On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…

Fred Hutch and Seattle Cancer Care Alliance unite, reshaped relationship with UW Medicine

On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…

Biotechnology | COVID-19 | Life Science News | Vaccine | Women's Health

Study suggested COVID-19 vaccines do not reduce fertility

On Feb. 8, 2022, a research team led at Boston University School of Public Health reported on links…

Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study

On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…

Severe COVID-19 in pregnancy associated with preterm birth, other complications

On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…

Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages

On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…

Rising protocol design complexity reported driving rapid growth in clinical trial data volume

On Jan. 12, 2021, the Tufts Center for the Study of Drug Development reported that ever more complex…

McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer

On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…

ADHD risk may be linked to inflammation during pregnancy

On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…

Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection

On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…

Women’s Health